MGN-8107

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameMGN-8107
Drug Alias NamemiR-206 targeted therapeutic (miRagen Therapeutics)MGN-8107
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > microRNA
Mechanisms of ActionMusculoskeletal system modulatorsNeuroprotectants
TargetsUpdating
Therapy Area/IndicationsAmyotrophic Lateral SclerosisMuscular Dystrophy, Duchenne
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesViridian Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesViridian Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral SclerosisMuscular Dystrophy, Duchenne

Other Information

ATC CodeN/A
Related LinksN/A